Compound |
Fa(%) |
Fa types |
Literature references |
Remarks |
Ganciclovir |
3 |
Low |
[176] |
|
Melagatran |
5 |
Low |
In-house |
|
Enalaprilat |
10 |
Low |
[177] |
|
Sulphasalazine |
12 |
Low |
[178] |
Drain substrate |
Acyclovir |
17 |
Low |
[128,180] |
|
Chlorothiazide |
25 |
Middle |
[178,180] |
Dose-dependent F;saturated abs |
Mannitol |
26 |
Middle |
[178,181] |
|
Atenolol |
56 |
Middle |
[178,182] |
|
Zomig |
60 |
Middle |
In-house |
|
Ranitidine |
61 |
Middle |
[183] |
The Fa value is calculated from Fa=F/(1-CLH/QH); With transport protein interaction |
Digoxin |
81 |
High |
[184] |
Static urinary excretion data, Fa values can be calculated from the oral and intravenous injection ;P-gp substrate |
Methotrexate |
82 |
High |
[185] |
Static urinary excretion data, Fa values can be calculated from the oral and intravenous injection; a decrease in absorption at high doses |
Quinidine |
90 |
High |
[186] |
The Fa value is calculated from Fa=F/(1-CLH/QH); P-gp/MRP inhibitor/substrate |
Antipyrine |
100 |
High |
[187] |
|
Caffeine |
100 |
High |
[188] |
|
Metoprolol |
100 |
High |
[178,189] |
|
probenecid |
100 |
High |
[190] |
MRP inhibitor/substrate |
Propranolol |
100 |
High |
[191] |
|
Testerone |
100 |
High |
[192] |
|
Theophylline |
100 |
High |
[193] |
|
Verapamil |
100 |
High |
[194] |
P-gp/MRP substrate inhibitor |
D-glucose |
100 |
High |
|
Glucose transport protein |
Glycine-proline |
100 |
High |
|
Dipeptide transport protein |
L-leucine |
100 |
High |
|
Amino acid transport protein |
L-phenylalanine |
100 |
High |
|
Amino acid transport protein |